Perinatology

The Korean Society of Perinatology (대한주산의학회)
권호 표지
DOI QR코드

DOI QR Code

Pregnancy and Neonatal Outcomes of Group B Streptococcus Infection in Preterm Births

  • Lee, Yae Heun (Department of Obstetric Gynecology, Gachon University College of Medicine) ;
  • Lee, Yoo Jung (Department of Obstetric Gynecology, Gachon University College of Medicine) ;
  • Jung, Sun Young (Department of Obstetric Gynecology, Gachon University College of Medicine) ;
  • Kim, Suk Young (Department of Obstetric Gynecology, Gachon University College of Medicine) ;
  • Son, Dong Woo (Department of Pediatrics, Gachon University College of Medicine) ;
  • Seo, Il Hye (Department of Clinical Pathology, Gachon University College of Medicine)
  • Received : 2018.03.20
  • Accepted : 2018.08.08
  • Published : 2018.12.31
⟨ Previous Next ⟩

Abstract

Objective: This study examines whether maternal group B Streptococcus (Streptococcus agalactiae, GBS) infection was associated with preterm births and premature neonatal outcomes. Methods: Maternal and neonatal outcomes were examined among singleton pregnant women with preterm birth (from $24^{+0}weeks$ to $36^{+6}weeks$) who were tested for GBS (n=203) during the pregnancy. Data were collected retrospectively from the medical records of women who delivered at our hospital from January 2015 to February 2017. We compared obstetrical factors (causes of preterm birth) and neonatal (gestational age at delivery, birth weight, Apgar score 1 min/5 min, hospitalization period, duration of mechanical ventilation, neonatal C-reactive protein within three days, and other complication [respiratory distress syndrome, neonatal deaths]) outcomes between GBS-infected and non-infected pregnant women. Results: There were 203 singleton pregnant women included in the study, 25 of whom were confirmed to have a GBS infection during the pregnancy. There was no difference in neonatal outcomes by GBS status. Preterm premature rupture of membranes (pPROM), as an obstetric factor, was associated with GBS infection (P=0.022). GBS infection raised the risk of pPROM by 3.6 times (odds ratio 3.648, 95% confidence interval 1.476-9.016, P=0.005). Conclusion: GBS infection in preterm birth was associated with pPROM but did not result in adverse neonatal outcomes. Continuous attention and evaluation of GBS infection, a major cause of neonatal sepsis and pneumonia, are needed.

Keywords

References

  1. Edwards MS, Nizet V, Baker CJ. Group B Streptococcal Infections. In: Remington JS, Klein JO, Wilson CB, et al. editors. Infectious Diseases of the Fetus and Newborn Infant. 7th ed, Philadelphia, Elsevier Saunders, 2011, p419-69.
  2. Eichenwald EC. Perinatally transmitted neonatal bacterial infections. Infect Dis Clin North Am 1997;11:223-39. https://doi.org/10.1016/S0891-5520(05)70350-0
  3. Verani JR, McGee L, Schrag SJ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010. MMWR Recomm Rep 2010;59(RR-10):1-36.
  4. Regan JA, Klebanoff MA, Nugent RP, Eschenbach DA, Blackwelder WC, Lou Y, et al. Colonization with group B streptococci in pregnancy and adverse outcome. VIP Study Group. Am J Obstet Gynecol 1996;174: 1354-60. https://doi.org/10.1016/S0002-9378(96)70684-1
  5. Krohn MA, Hillier SL, Baker CJ. Maternal peripartum complications associated with vaginal group B streptococci colonization. J Infect Dis 1999; 179:1410-5. https://doi.org/10.1086/314756
  6. Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 2008;299:2056-65. https://doi.org/10.1001/jama.299.17.2056
  7. Koenig JM, Keenan WJ. Group B streptococcus and early-onset sepsis in the era of maternal prophylaxis. Pediatr Clin North Am 2009;56:689-708, Table of Contents. https://doi.org/10.1016/j.pcl.2009.04.003
  8. Gerdes JS. Diagnosis and management of bacterial infections in the neonate. Pediatr Clin North Am 2004;51:939-59, viii-ix. https://doi.org/10.1016/j.pcl.2004.03.009
  9. Heath PT, Balfour G, Weisner AM, Efstratiou A, Lamagni TL, Tighe H, et al. Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet 2004;363:292-4. https://doi.org/10.1016/S0140-6736(03)15389-5
  10. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 2002;51(RR-11):1-22.
  11. Van Dyke MK, Phares CR, Lynfield R, Thomas AR, Arnold KE, Craig AS, et al. Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med 2009;360:2626-36. https://doi.org/10.1056/NEJMoa0806820
  12. Benitz WE, Gould JB, Druzin ML. Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review. Pediatrics 1999;103:e77. https://doi.org/10.1542/peds.103.6.e77
  13. Hong JS, Choi CW, Park KU, Kim SN, Lee HJ, Lee HR, et al. Genital group B Streptococcus carrier rate and serotype distribution in Korean pregnant women: implications for group B streptococcal disease in Korean neonates. J Perinat Med 2010;38:373-7.
  14. Lee BK, Song YR, Kim MY, Yang JH, Shin JH, Seo YS, et al. Epidemiology of group B streptococcus in Korean pregnant women. Epidemiol Infect 2010;138:292-8. https://doi.org/10.1017/S0950268809990859
  15. Zhang LX, Sun Y, Zhao H, Zhu N, Sun XD, Jin X, et al. A bayesian stepwise discriminant model for predicting risk factors of preterm premature rupture of membranes: a case-control study. Chin Med J (Engl) 2017; 130:2416-22. https://doi.org/10.4103/0366-6999.216396
  16. Yoon IA, Jo DS, Cho EY, Choi EH, Lee HJ, Lee H. Clinical significance of serotype V among infants with invasive group B streptococcal infections in South Korea. Int J Infect Dis 2015;38:136-40. https://doi.org/10.1016/j.ijid.2015.05.017
  17. Persson E, Berg S, Trollfors B, Larsson P, Ek E, Backhaus E, et al. Serotypes and clinical manifestations of invasive group B streptococcal infections in western Sweden 1998-2001. Clin Microbiol Infect 2004;10:791-6. https://doi.org/10.1111/j.1469-0691.2004.00931.x
  18. Lachenauer CS, Kasper DL, Shimada J, Ichiman Y, Ohtsuka H, Kaku M, et al. Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. J Infect Dis 1999;179:1030-3. https://doi.org/10.1086/314666
  19. El Aila NA, Tency I, Claeys G, Saerens B, Cools P, Verstraelen H, et al. Comparison of different sampling techniques and of different culture methods for detection of group B streptococcus carriage in pregnant women. BMC Infect Dis 2010;10:285. https://doi.org/10.1186/1471-2334-10-285
  20. Benitz WE, Gould JB, Druzin ML. Antimicrobial prevention of early-onset group B streptococcal sepsis: estimates of risk reduction based on a critical literature review. Pediatrics 1999;103:e78. https://doi.org/10.1542/peds.103.6.e78
  21. Ganor-Paz Y, Kailer D, Shechter-Maor G, Regev R, Fejgin MD, Biron-Shental T. Obstetric and neonatal outcomes after preterm premature rupture of membranes among women carrying group B streptococcus. Int J Gynaecol Obstet 2015;129:13-6. https://doi.org/10.1016/j.ijgo.2014.10.024